Jesús González de la Aleja

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Venues

European journal of neurology

Neuroradiology

Neurology

Epileptic disorders : international epilepsy journal with videotape

Hospital Universitario 12 de Octubre.

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital Universitario 12 de Octubre.

Spain

Staff Neurologist. :: Epilepsy-EEG Unit.

Publications

Sara Bellido-Cuéllar, Ana Arteche-López, Miguel A Martín, Rosa Ana Saiz-Díaz, Jesús González de la Aleja
Comment on: Soft cerebellar signs unveil RARS2-related epilepsy. Epileptic disorders : international epilepsy journal with videotape (2024)
María Paz Guerrero-Molina, Ángela Bernabeu-Sanz, Ana Ramos-González, Montserrat Morales-Conejo, Aitor Delmiro, Cristina Domínguez-González, Joaquín Arenas, Miguel Angel Martin, Jesús González de la Aleja
Magnetic resonance spectroscopy in MELAS syndrome: correlation with CSF and plasma metabolite levels and change after glutamine supplementation. Neuroradiology (2023)
María Paz Guerrero-Molina, Cristina Domínguez-González, Jesús González de la Aleja
Reply: High-dose oral glutamine can reduce cerebrospinal fluid glutamate in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes without a beneficial clinical or cerebral tissue effect. European journal of neurology 30 (4) (2023)
María Paz Guerrero-Molina, Ángela Bernabeu-Sanz, Ana Ramos-González, Montserrat Morales-Conejo, Aitor Delmiro, Cristina Domínguez-González, Joaquín Arenas, Miguel Angel Martin, Jesús González de la Aleja
Magnetic resonance spectroscopy in MELAS syndrome: correlation with CSF and plasma metabolite levels and change after glutamine supplementation. Neuroradiology 66 (3) (2023)
María Paz Guerrero-Molina, Cristina Domínguez-González, Jesús González de la Aleja
Reply: High-dose oral glutamine can reduce cerebrospinal fluid glutamate in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes without a beneficial clinical or cerebral tissue effect. European journal of neurology 30 (4) (2023)
María Paz Guerrero-Molina, Ángela Bernabeu-Sanz, Ana Ramos-González, Montserrat Morales-Conejo, Aitor Delmiro, Cristina Domínguez-González, Joaquín Arenas, Miguel Angel Martin, Jesús González de la Aleja
Magnetic resonance spectroscopy in MELAS syndrome: correlation with CSF and plasma metabolite levels and change after glutamine supplementation. Neuroradiology 66 (3) (2023)
María Paz Guerrero-Molina, Ángela Bernabeu-Sanz, Ana Ramos-González, Montserrat Morales-Conejo, Aitor Delmiro, Cristina Domínguez-González, Joaquín Arenas, Miguel Angel Martin, Jesús González de la Aleja
Magnetic resonance spectroscopy in MELAS syndrome: correlation with CSF and plasma metabolite levels and change after glutamine supplementation. Neuroradiology 66 (3) (2023)
María Paz Guerrero-Molina, Ángela Bernabeu-Sanz, Ana Ramos-González, Montserrat Morales-Conejo, Aitor Delmiro, Cristina Domínguez-González, Joaquín Arenas, Miguel Angel Martin, Jesús González de la Aleja
Magnetic resonance spectroscopy in MELAS syndrome: correlation with CSF and plasma metabolite levels and change after glutamine supplementation. Neuroradiology 66 (3) (2023)
María Paz Guerrero-Molina, Cristina Domínguez-González, Jesús González de la Aleja
Reply: High-dose oral glutamine can reduce cerebrospinal fluid glutamate in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes without a beneficial clinical or cerebral tissue effect. European journal of neurology (2023)
María Paz Guerrero-Molina, Cristina Domínguez-González, Jesús González de la Aleja
Reply: High-dose oral glutamine can reduce cerebrospinal fluid glutamate in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes without a beneficial clinical or cerebral tissue effect. European journal of neurology 30 (4) (2023)
María Paz Guerrero-Molina, Cristina Domínguez-González, Jesús González de la Aleja
Reply: High-dose oral glutamine can reduce CSF glutamate in MELAS without a beneficial clinical or cerebral tissue effect. European journal of neurology (2023)
María Paz Guerrero-Molina, Montserrat Morales-Conejo, Aitor Delmiro, María Morán, Cristina Domínguez-González, Elena Arranz-Canales, Ana Ramos-González, Joaquín Arenas, Miguel Angel Martin, Jesús González de la Aleja
Elevated glutamate and decreased glutamine levels in the cerebrospinal fluid of patients with MELAS syndrome. Journal of neurology 269 (6) (2022)
María Paz Guerrero-Molina, Montserrat Morales-Conejo, Aitor Delmiro, María Morán, Cristina Domínguez-González, Elena Arranz-Canales, Ana Ramos-González, Joaquín Arenas, Miguel Angel Martin, Jesús González de la Aleja
High-dose oral glutamine supplementation reduces elevated glutamate levels in cerebrospinal fluid in patients with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes syndrome. European journal of neurology (2022)
Antonio Méndez-Guerrero, Víctor Antonio Blanco-Palmero, María Isabel Laespada-García, Francisco Javier Azcárate-Díaz, Jesús González de la Aleja
Author Response: Acute Hypokinetic-Rigid Syndrome After SARS-CoV-2 Infection. Neurology 96 (9) (2021)
Antonio Méndez-Guerrero, María Isabel Laespada-García, Adolfo Gómez-Grande, Mariano Ruiz-Ortiz, Víctor Antonio Blanco-Palmero, Francisco Javier Azcarate-Diaz, Pablo Rábano-Suárez, Eva Álvarez-Torres, Carlos Pablo de Fuenmayor-Fernández de la Hoz, Diana Vega Pérez, Raquel Rodríguez-Montalbán, Alfredo Pérez-Rivilla, Javier Sayas Catalán, Ana Ramos-González, Jesús González de la Aleja
Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection. Neurology 95 (15) (2020)

Jesús González de la Aleja.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jesús González de la Aleja